Majedie Asset Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Majedie Asset Management's NVS Position: Q1 2022 in Review
Majedie Asset Management opened a new position in Novartis (NVS) in Q1 2022: 113,784 shares worth $9.96M. The stake represents 0.82% of the portfolio and ranks #38 among its holdings. This is a return to the name: Majedie Asset Management previously reported a position in NVS as recently as Q4 2018.
Majedie Asset Management first reported a position in NVS in Q4 2018 and has held it in 2 quarters since. The position peaked at $56M in Q4 2018. 1,137 funds tracked by Wall St. Rank hold NVS as of Q1 2022.
- Majedie Asset Management held 113,784 shares of Novartis worth $9.96M as of Q1 2022.
- Novartis was a new Majedie Asset Management position in Q1 2022.
- Novartis made up 0.82% of Majedie Asset Management's portfolio in Q1 2022, its #38 holding.
- Majedie Asset Management first reported a position in Novartis in Q4 2018 and has held it in 2 quarters since.
- Majedie Asset Management's Novartis position peaked at $56M in Q4 2018.
- 1,137 funds tracked by Wall St. Rank held Novartis as of Q1 2022.
Based on Majedie Asset Management's 13F filing for Q1 2022, filed 16 May 2022.